Our own examination of Tks5 using tissue microarrays revealed an increased Tks5 expression in clinical breast cancer specimens, with approximately half of primary invasive tumors displaying high Tks5 protein expression. The gene discussed is SH3PXD2A; the disease is breast carcinoma.